1. Home
  2. YSXT vs CUE Comparison

YSXT vs CUE Comparison

Compare YSXT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSXT
  • CUE
  • Stock Information
  • Founded
  • YSXT 2011
  • CUE 2014
  • Country
  • YSXT China
  • CUE United States
  • Employees
  • YSXT N/A
  • CUE N/A
  • Industry
  • YSXT Automotive Aftermarket
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSXT Consumer Discretionary
  • CUE Health Care
  • Exchange
  • YSXT Nasdaq
  • CUE Nasdaq
  • Market Cap
  • YSXT 87.9M
  • CUE 91.9M
  • IPO Year
  • YSXT 2024
  • CUE 2018
  • Fundamental
  • Price
  • YSXT $2.36
  • CUE $1.42
  • Analyst Decision
  • YSXT
  • CUE Strong Buy
  • Analyst Count
  • YSXT 0
  • CUE 5
  • Target Price
  • YSXT N/A
  • CUE $5.00
  • AVG Volume (30 Days)
  • YSXT 73.1K
  • CUE 261.2K
  • Earning Date
  • YSXT 01-01-0001
  • CUE 03-10-2025
  • Dividend Yield
  • YSXT N/A
  • CUE N/A
  • EPS Growth
  • YSXT N/A
  • CUE N/A
  • EPS
  • YSXT 0.21
  • CUE N/A
  • Revenue
  • YSXT $58,546,729.00
  • CUE $9,532,000.00
  • Revenue This Year
  • YSXT N/A
  • CUE $73.11
  • Revenue Next Year
  • YSXT N/A
  • CUE $11.02
  • P/E Ratio
  • YSXT $11.85
  • CUE N/A
  • Revenue Growth
  • YSXT 18.92
  • CUE 149.53
  • 52 Week Low
  • YSXT $2.06
  • CUE $0.45
  • 52 Week High
  • YSXT $6.27
  • CUE $2.37
  • Technical
  • Relative Strength Index (RSI)
  • YSXT N/A
  • CUE 55.26
  • Support Level
  • YSXT N/A
  • CUE $1.22
  • Resistance Level
  • YSXT N/A
  • CUE $1.50
  • Average True Range (ATR)
  • YSXT 0.00
  • CUE 0.12
  • MACD
  • YSXT 0.00
  • CUE -0.01
  • Stochastic Oscillator
  • YSXT 0.00
  • CUE 73.33

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Share on Social Networks: